Demographic and clinical characteristics of DENV-3 cases, Hospital Study, 2005–11.

1In the hospital study, immune response is known in 109, 168, and 99 DENV-3 cases in years 2008–9, 2009–10, and 2010–11, respectively.2Hemorrhagic manifestations do not include laboratory values and are defined as presence of any of the following clinical signs and symptoms: petechiae, rash, positive tourniquet test, bruising, hematoma, hemoptysis, epistaxis, gingivorrhagia, melena, hematemesis, hematuria, subconjunctival hemorrhage, vaginal hemorrhage, hypermenorrhea and excessive bleeding at puncture site.3p-values were calculated using the Chi-square tests, except for mean age and mean day of presentation, for which Mann-Whitney t-tests were applied.